See All
Preferences
My Communities
My Discussions
My Email Digests


Overall, the study found that 0.63% (34/5431) of people using varenicline experienced a serious cardiovascular event, as compared with 0.47% (18/3801) of those using placebo pills. This new study possibly came to a different conclusion than the previous review on this topic because it focused on events occurring while people were taking the drug and for 30 days thereafter. The previous study included events occurring throughout the whole duration of follow-up and did not correct for the fact that varenicline treated patients were more likely to participate in the follow-ups (and therefore report events), partly because they were much more likely to quit smoking.
The study authors, Drs Judith Prochaska and Joan Hilton of the University of California, concluded that, "Our meta-analysis of treatment emergent, cardiovascular serious adverse events, ... indicates that the risk of these events associated with varenicline use is small, and statistically and clinically insignificant."
I wonder if WebMD is going to report this new finding?View Thread


1. How many cigarettes per day do you smoke?
2. How soon after you wake do you smoke your first cigarette of the day?
Those who smoke more than 30 cigarettes per day or smoke within 5 minutes of waking in the morning have a lower quit rate than those who smoke less than 11 cigarettes per day and typically don't smoke their first of the day until over an hour after waking in the morning. It appears that these two questions on their own can give a reasonable but fairly rough guide to how addicted a smoker is. I say "fairly rough" because even among those scoring a zero on these addiction assessments (i.e. the least addicted), the six month quit rate among those receiving placebo in the clinical trials was only twenty percent. This suggests to me that significant addiction is present among people who smoke less than 11 cigarettes per day. It also suggests that we need some additional questions that can help measure level of addiction at the low levels of daily cigarette consumption (i.e. <11 per day). It is unclear whether an individual actively delaying the first smoke of the day and reducing their daily cigarette consumption over time can make themselves "less addicted". It is possible, if sustained over a reasonably long period (i.e. greater than a month). However, perhaps a more practical use of these types of quick addiction assessments is to guide the smoker about whether they would likely benefit from assistance in quitting (e.g. counseling and/or medication). It seems that people who smoke just a few cigarettes per day and don't smoke within an hour of waking in the morning may have a good chance of success by picking a day and making a serious quit attempt on their own. Heavier smokers may be more likely to benefit from additional assistance. However, in this recent study, even those who had a zero score on the addiction questionnaires were more than twice as likely to successfully quit smoking for 6 months if they received varenicline as compared to those receiving placebo (47% v 20%).View Thread


Have a look, tell us what you think, and vote for the one you believe may be most effective in motivating smokers to quit.View Thread
Take the Poll
Poll Results
-
Anthem Ad0% (0)
-
Buergers Disease Ad0% (0)
-
Cessation Tips Ad40% (2)
-
Terri's Ad20% (1)
-
One of the other ads40% (2)

At one month follow-up, more women receiving nicotine patches than placebo patches had quit (21% v 12%). However, only 7% of the nicotine patch group and 3% of the placebo patch group continued with the second month of patches. By delivery of the babies, there was no significant difference in quit rates between the two groups (9% v 8%). The study also measured a range of side effects and pregnancy outcomes and for most of these there were no differences between nicotine and placebo patches. For example, 6% of both groups reported neonatal adverse events, and the birth weight of the babies was very similar in both groups. The authors concluded that adding 15mg daily nicotine patches to brief behavioral counseling for pregnant smokers neither increases the quit rates, nor increases the risk of adverse pregnancy or birth outcomes.
A couple of things are striking about the results. The first is that, despite being seemingly highly motivated to quit smoking, less than one in five managed to quit for a month, and less than 10% were quit at the time of delivery (around 5 months after initially trying to quit). The other striking result is the very low compliance with patch use and the low use of additional counseling. 76% of those given placebo patches and 60% of those given nicotine patches used them for less than 15 days. The lower patch use in the placebo group suggests this was not caused by nicotine-related side-effects. Part of this early termination of patch use may be due to a perception that they were not helping to quit smoking, and part may have been (ironically) due to concerns about potential harm to the baby.(Ironic because there is much greater harm to the baby from continued smoking). In particular, it is likely that women would have stopped using the patches when they had a smoking lapse, because of (misplaced) concern that smoking while using the patch may be particularly harmful. The women were also given the opportunity for additional face-to-face counseling sessions but only around 10% did so. Clearly the search must continue for widely applicable and effective ways to help pregnant smokers to quit.
View Thread

This study, perhaps the most detailed of its kind, reminds us that quitting smoking is best conceptualized as a process requiring efforts, often repeated, over a long period of time, rather than as a single event.
Reference: Borland et al (2012). How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country Cohort Study. Addiction, 107, issue 3. P673-682.View Thread


There are many serious problems with this study (such as the low 38% overall follow-up rate), but the main problems lie with the misunderstanding of the purpose of tobacco dependence treatment and the misinterpretation of the data presented. Nicotine replacement therapy is currently marketed for short term use as an aid to smoking cessation. Counseling is similarly primarily conducted to help current smokers to successfully quit. Both of these interventions have been shown to increase the chances that smokers will successfully quit, but there is no evidence, from randomized controlled trials or population studies suggesting that after the medication or counseling has stopped that the relapse rate is dramatically different than from smokers who quit without treatment. So the benefit of treatment is of increasing the initial quit rates, meaning that even with similar relapse rates, there are more long term quitters. So for this study to ignore the first part, the "getting quit" and then focus on the second part, the "staying quit" and to find no difference is really unsurprising .
There are other surprising weaknesses in this report, including a failure to cite other population studies that fail to support the claimed findings of this study. For example, a population-based study published by West and colleagues in 2007 concluded that NRT use by smokers making self-initiated quit attempts without behavioral support is associated with improved long term abstinence rates. Amazingly the authors failed to cite recent population-based studies from their own state finding that use of a comprehensive tobacco cessation pharmacotherapy Medicaid benefit was associated with a significant decrease in smoking prevalence and claims for hospitalizations for acute myocardial infarction and acute coronary heart disease .
So does this recent study show that NRT doesn't help smokers to quit? No. Despite the headlines, this wasn't even a study of whether NRT use helps smokers to quit. Rather it was a rather weak study of whether people who quit smoking a long time ago have a tendency to relapse long after. The sad reality is that relapse continues. But of course this is a long recognized characteristic of an addiction, not a new finding. So this study has little bearing on the solid evidence that nicotine replacement therapy helps smokers to quit, and that tobacco treatment remains one of the most cost effective healthcare interventions available.View Thread
See Related Mental Health Communities
Women's Health Newsletter
Find out what women really need.
Other Smoking Cessation Information
More Related Communities
The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatments or uses of drug products that have not been approved by the U.S. Food and Drug Administration. WebMD does not endorse any specific product, service, or treatment.
Do not consider WebMD User-generated content as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.
Health Solutions From Our Sponsors
©2005-2013 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.



